Research into the therapeutic roles of two-pore-domain potassium channels
- PMID: 20951446
- DOI: 10.1016/j.tips.2010.09.001
Research into the therapeutic roles of two-pore-domain potassium channels
Abstract
The K(2P) potassium channels are responsible for the background conductance observed in several tissues. Their ubiquitous localization and thus their potential implications in diseases have led to increased research on these channels over the last few years. In this review, we outline different aspects of the research on K(2P) channels and highlight some of the latest discoveries in this area. We focus on research into K(2P) channels as potential therapeutic targets in ischemia/hypoxia, depression, memory disorders, pain, cardiovascular disease and disorders of the immune system. We address the challenge of developing novel pharmacological compounds to target these channels. We also discuss the regulation of expression of the K(2P) gene in health and disease, as well as the value of assessing the expression of K(2P) channels as potential biomarkers of disease.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
K(+) channels as therapeutic targets in oncology.Future Med Chem. 2010 May;2(5):745-55. doi: 10.4155/fmc.10.24. Future Med Chem. 2010. PMID: 21426201 Review.
-
Patents related to therapeutic activation of K(ATP) and K(2P) potassium channels for neuroprotection: ischemic/hypoxic/anoxic injury and general anesthetics.Expert Opin Ther Pat. 2009 Apr;19(4):433-60. doi: 10.1517/13543770902765151. Expert Opin Ther Pat. 2009. PMID: 19441925 Review.
-
Pharmacology of cardiac potassium channels.Adv Pharmacol. 2010;59:93-134. doi: 10.1016/S1054-3589(10)59004-5. Adv Pharmacol. 2010. PMID: 20933200 Review.
-
Potassium channel blockers and openers as CNS neurologic therapeutic agents.Recent Pat CNS Drug Discov. 2007 Nov;2(3):200-28. doi: 10.2174/157488907782411765. Recent Pat CNS Drug Discov. 2007. PMID: 18221232 Review.
-
Upregulation of K2P5.1 potassium channels in multiple sclerosis.Ann Neurol. 2010 Jul;68(1):58-69. doi: 10.1002/ana.22010. Ann Neurol. 2010. PMID: 20582984
Cited by
-
KCNK1 promotes proliferation and metastasis of breast cancer cells by activating lactate dehydrogenase A (LDHA) and up-regulating H3K18 lactylation.PLoS Biol. 2024 Jun 21;22(6):e3002666. doi: 10.1371/journal.pbio.3002666. eCollection 2024 Jun. PLoS Biol. 2024. PMID: 38905316 Free PMC article.
-
A hydrophobic barrier deep within the inner pore of the TWIK-1 K2P potassium channel.Nat Commun. 2014 Jul 8;5:4377. doi: 10.1038/ncomms5377. Nat Commun. 2014. PMID: 25001086 Free PMC article.
-
Nuclear receptor CAR specifically activates the two-pore K+ channel Kcnk1 gene in male mouse livers, which attenuates phenobarbital-induced hepatic hyperplasia.Toxicol Sci. 2013 Mar;132(1):151-61. doi: 10.1093/toxsci/kfs338. Epub 2013 Jan 4. Toxicol Sci. 2013. PMID: 23291559 Free PMC article.
-
The inhibitor of volume-regulated anion channels DCPIB activates TREK potassium channels in cultured astrocytes.Br J Pharmacol. 2013 Mar;168(5):1240-54. doi: 10.1111/bph.12011. Br J Pharmacol. 2013. PMID: 23072356 Free PMC article.
-
SUMOylation and calcium signalling: potential roles in the brain and beyond.Neuronal Signal. 2017 Jul 19;1(3):NS20160010. doi: 10.1042/NS20160010. eCollection 2017 Aug. Neuronal Signal. 2017. PMID: 32714579 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical